Cevdet Samikoglu

Amministratore Delegato presso Biosplice Therapeutics, Inc.

Finance

Commercial Services

Profilo

Cevdet Samikoglu is currently the Chief Executive Officer and Director at Biosplice Therapeutics, Inc. Prior to this, he worked as a Partner at Greywolf Capital Management LP.

Posizioni attive di Cevdet Samikoglu

Società	Posizione	Inizio
Biosplice Therapeutics, Inc. Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA.	Amministratore Delegato	01/03/2021

Tutte le posizioni attive di Cevdet Samikoglu

Precedenti posizioni note di Cevdet Samikoglu

Società	Posizione	Fine
Greywolf Capital Management LP Greywolf Capital Management LP Investment ManagersFinance Greywolf Capital Management LP (Greywolf Capital) is an independent, SEC-registered investment advisor and hedge fund firm headquartered in Purchase, New York. The firm was founded in 2003 by Bob Miller, Jonathan Savitz, William Troy and James Gillespie. Greywolf Capital provides investment advisory services to (i) private investment funds that are primarily offered to institutional investors and financially sophisticated high net worth individuals and (ii) separately managed accounts, primarily for the foregoing types of investors.	Gestore di Portafoglio-Azioni	-

Vedi nel dettaglio l'esperienza di Cevdet Samikoglu

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Cevdet Samikoglu

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Greywolf Capital Management LP Greywolf Capital Management LP Investment ManagersFinance Greywolf Capital Management LP (Greywolf Capital) is an independent, SEC-registered investment advisor and hedge fund firm headquartered in Purchase, New York. The firm was founded in 2003 by Bob Miller, Jonathan Savitz, William Troy and James Gillespie. Greywolf Capital provides investment advisory services to (i) private investment funds that are primarily offered to institutional investors and financially sophisticated high net worth individuals and (ii) separately managed accounts, primarily for the foregoing types of investors.	Finance
Biosplice Therapeutics, Inc. Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA.	Commercial Services